• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管胃交界部以胃为主型腺癌经腹食管裂孔胃切除术及淋巴结清扫的最佳范围:中国单中心回顾性研究

Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China.

作者信息

Zhao Baoyu, Zhang Zhenzhan, Mo Debin, Lu Yiming, Hu Yanfeng, Yu Jiang, Liu Hao, Li Guoxin

机构信息

Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Department of General Surgery, Shanxi Provincial People's Hospital, Taiyuan, China.

出版信息

Front Oncol. 2019 Jan 21;8:639. doi: 10.3389/fonc.2018.00639. eCollection 2018.

DOI:10.3389/fonc.2018.00639
PMID:30719422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6348947/
Abstract

The optimal extent of gastrectomy and lymphadenectomy for esophagogastric junction (EGJ) cancer is controversial. Our study aimed to compare the long-term survival of transhiatal proximal gastrectomy with extended periproximal lymphadenectomy (THPG with EPL) and transhiatal total gastrectomy with complete perigastric lymphadenectomy (THTG with CPL) for patients with the stomach-predominant EGJ cancer. Between January 2004, and August 2015, 306 patients with Siewert II tumors were divided into the THTG group ( = 148) and the THPG group ( = 158). Their long-term survival was compared according to Nishi's classification. The Kaplan-Meier method and Cox proportional hazards models were used for survival analysis. There were no significant differences between the two groups in the distribution of age, gender, tumor size or Nishi's type ( > 0.05). However, a significant difference was observed in terms of pathological tumor stage ( < 0.05). The 5-year overall survival rates were 62.0% in the THPG group and 59.5% in the THTG group. The hazard ratio for death was 0.455 (95% CI, 0.337 to 0.613; log-rank < 0.001). Type GE/E = G showed a worse prognosis compared with Type G ( < 0.05). Subgroup analysis stratified by Nishi's classification, Stage IA-IIB and IIIA, and tumor size ≤ 30 mm indicated significant survival advantages for the THPG group ( < 0.05). However, this analysis failed to show a survival benefit in Stage IIIB ( > 0.05). Nishi's classification is an effective method to clarify the subdivision of Siewert II tumors with a diameter ≤ 40 mm above or below the EGJ. THPG with EPL is an optimal procedure for the patients with the stomach-predominant EGJ tumors ≤30 mm in diameter and in Stage IA-IIIA. For more advanced and larger EGJ tumors, further studies are required to confirm the necessity of THTG with CPL.

摘要

食管胃交界(EGJ)癌的最佳胃切除范围和淋巴结清扫范围存在争议。我们的研究旨在比较经胸近端胃切除术联合扩大近端周围淋巴结清扫术(THPG联合EPL)和经胸全胃切除术联合完整胃周淋巴结清扫术(THTG联合CPL)治疗以胃为主的EGJ癌患者的长期生存率。2004年1月至2015年8月期间,306例Siewert II型肿瘤患者被分为THTG组(n = 148)和THPG组(n = 158)。根据Nishi分类比较两组的长期生存率。采用Kaplan-Meier法和Cox比例风险模型进行生存分析。两组在年龄、性别、肿瘤大小或Nishi类型分布上无显著差异(P>0.05)。然而,在病理肿瘤分期方面观察到显著差异(P<0.05)。THPG组的5年总生存率为62.0%,THTG组为59.5%。死亡风险比为0.455(95%CI,0.337至0.613;对数秩检验P<0.001)。GE/E = G型与G型相比预后较差(P<0.05)。按Nishi分类、IA-IIB期和IIIA期以及肿瘤大小≤30 mm进行亚组分析,结果显示THPG组具有显著的生存优势(P<0.05)。然而,该分析未能显示IIIB期有生存获益(P>0.05)。Nishi分类是一种有效的方法,可明确EGJ上方或下方直径≤40 mm的Siewert II型肿瘤的细分情况。THPG联合EPL是治疗直径≤30 mm且处于IA-IIIA期以胃为主的EGJ肿瘤患者的最佳手术方式。对于更晚期和更大的EGJ肿瘤,需要进一步研究以证实THTG联合CPL的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/e67bddc6aa81/fonc-08-00639-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/f53a0c2a76db/fonc-08-00639-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/0b611006477a/fonc-08-00639-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/47811b7ed07c/fonc-08-00639-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/9d2888e55612/fonc-08-00639-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/e67bddc6aa81/fonc-08-00639-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/f53a0c2a76db/fonc-08-00639-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/0b611006477a/fonc-08-00639-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/47811b7ed07c/fonc-08-00639-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/9d2888e55612/fonc-08-00639-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f56/6348947/e67bddc6aa81/fonc-08-00639-g0005.jpg

相似文献

1
Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China.食管胃交界部以胃为主型腺癌经腹食管裂孔胃切除术及淋巴结清扫的最佳范围:中国单中心回顾性研究
Front Oncol. 2019 Jan 21;8:639. doi: 10.3389/fonc.2018.00639. eCollection 2018.
2
[Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].[经胸与经腹入路治疗食管胃交界部Siewert II型腺癌的生存比较:胸外科与胃肠外科联合数据分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):132-142.
3
[Survival rate of proximal and total gastrectomy in treatment of esophagogastric junction adenocarcinoma (Siewert II( Types)].食管胃交界腺癌(Siewert II型)近端胃切除术与全胃切除术的生存率
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Feb;19(2):195-9.
4
True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends.真性食管胃交界腺癌:其定义背景及当前手术趋势
Surg Today. 2020 Aug;50(8):809-814. doi: 10.1007/s00595-019-01843-4. Epub 2019 Jul 5.
5
Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.在Siewert II型肿瘤中,受累腹部淋巴结的分布与食管胃交界部至肿瘤远端的距离相关。
Eur J Surg Oncol. 2015 Oct;41(10):1348-53. doi: 10.1016/j.ejso.2015.05.004. Epub 2015 Jun 4.
6
Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.一项关于食管胃交界癌淋巴结清扫术的全国性回顾性研究结果。
Gastric Cancer. 2017 Mar;20(Suppl 1):69-83. doi: 10.1007/s10120-016-0663-8. Epub 2016 Oct 28.
7
Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.腹腔镜与开腹经食管裂孔入路手术治疗食管胃交界部 Siewert Ⅱ型腺癌的短期疗效比较。
Surg Endosc. 2018 Jan;32(1):383-390. doi: 10.1007/s00464-017-5687-6. Epub 2017 Jun 27.
8
Transhiatal distal esophagectomy for Siewert type II cardia cancer can be a treatment option in selected patients.经食管裂孔食管下段切除术治疗 Siewert Ⅱ型贲门癌可作为某些患者的一种治疗选择。
Eur J Surg Oncol. 2019 Oct;45(10):1943-1949. doi: 10.1016/j.ejso.2019.04.001. Epub 2019 Apr 13.
9
Treatment of the adenocarcinoma of the esophagogastric junction at a single institution in Mexico.墨西哥一家机构对食管胃交界腺癌的治疗。
Ann Surg Oncol. 2007 Apr;14(4):1439-48. doi: 10.1245/s10434-006-9216-4. Epub 2007 Jan 18.
10
[Optimal surgical approach for esophagogastric junction carcinoma].[食管胃交界部癌的最佳手术方式]
Nihon Geka Gakkai Zasshi. 2015 Jan;116(1):40-4.

引用本文的文献

1
Subclassification scheme for adenocarcinomas of the esophagogastric junction and prognostic analysis based on clinicopathological features.食管胃交界腺癌的亚分类方案及基于临床病理特征的预后分析
World J Gastrointest Oncol. 2025 Apr 15;17(4):103455. doi: 10.4251/wjgo.v17.i4.103455.
2
A deep learning model to predict dose distributions for breast cancer radiotherapy.一种用于预测乳腺癌放射治疗剂量分布的深度学习模型。
Discov Oncol. 2025 Feb 12;16(1):165. doi: 10.1007/s12672-025-01942-4.
3
Updated epidemiology of gastrointestinal cancers in East Asia.

本文引用的文献

1
The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.胃食管交界部Siewert II/III型腺癌中幽门旁淋巴结转移的预后相关性
Eur J Surg Oncol. 2017 Dec;43(12):2333-2340. doi: 10.1016/j.ejso.2017.08.017. Epub 2017 Sep 8.
2
Japanese Classification of Esophageal Cancer, 11th Edition: part II and III.《日本食管癌分类》第11版:第二部分和第三部分
Esophagus. 2017;14(1):37-65. doi: 10.1007/s10388-016-0556-2. Epub 2016 Nov 10.
3
Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
东亚地区胃肠道癌症的最新流行病学情况。
Nat Rev Gastroenterol Hepatol. 2023 May;20(5):271-287. doi: 10.1038/s41575-022-00726-3. Epub 2023 Jan 11.
4
Total laparoscopic versus laparoscopic-assisted transabdominal posterior mediastinal digestive tract reconstruction in the treatment of Siewert II adenocarcinoma of the esophagogastric junction: A retrospective study.全腹腔镜与腹腔镜辅助经腹后纵隔消化道重建治疗食管胃交界部Siewert II型腺癌的回顾性研究
Front Surg. 2022 Aug 19;9:874857. doi: 10.3389/fsurg.2022.874857. eCollection 2022.
一项关于食管胃交界癌淋巴结清扫术的全国性回顾性研究结果。
Gastric Cancer. 2017 Mar;20(Suppl 1):69-83. doi: 10.1007/s10120-016-0663-8. Epub 2016 Oct 28.
4
Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction.远端食管或胃食管结合部腺癌患者淋巴结转移部位的预后意义。
Ann Surg. 2016 Nov;264(5):847-853. doi: 10.1097/SLA.0000000000001767.
5
Japanese gastric cancer treatment guidelines 2014 (ver. 4).《日本胃癌治疗指南2014(第4版)》
Gastric Cancer. 2017 Jan;20(1):1-19. doi: 10.1007/s10120-016-0622-4. Epub 2016 Jun 24.
6
Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.Siewert II型和III型食管胃交界癌预后的差异取决于基线肿瘤分期,而非其解剖位置。
Eur J Surg Oncol. 2016 Aug;42(8):1215-21. doi: 10.1016/j.ejso.2016.04.061. Epub 2016 May 24.
7
Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.食管胃交界腺癌的多模式治疗概述
Gen Thorac Cardiovasc Surg. 2015 Oct;63(10):549-56. doi: 10.1007/s11748-015-0575-2. Epub 2015 Aug 1.
8
Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.在Siewert II型肿瘤中,受累腹部淋巴结的分布与食管胃交界部至肿瘤远端的距离相关。
Eur J Surg Oncol. 2015 Oct;41(10):1348-53. doi: 10.1016/j.ejso.2015.05.004. Epub 2015 Jun 4.
9
Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients.贲门癌应采用食管切除术还是全胃切除术治疗?对4996例NSQIP/SEER患者的综合分析。
J Am Coll Surg. 2015 Apr;220(4):510-20. doi: 10.1016/j.jamcollsurg.2014.12.024. Epub 2014 Dec 29.
10
Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China.1988 - 2012年手术患者中食管胃交界腺癌和胃食管反流病的变化:中国一家高容量单机构经验
Ann Surg. 2016 Jan;263(1):88-95. doi: 10.1097/SLA.0000000000001148.